Table 1. Clinical features of the patients from whom prostate cell lines were derived.
Cell Line | Age | Race | Morphology/ AR & Response | Clinical Stage | Tumor Grade | Gleason Score |
---|---|---|---|---|---|---|
RWPE-1 | 54 | CA | Epithelial (AR+) | Non-malignant | N/A | N/A |
LNCAP | 50 | CA | Epithelial (AR+) | Adenocarcinoma metastatic Lymph node tumor | N/A | N/A |
RC77N-E | 62 | AA | Epithelial (AR+) | Non-malignant | N/Ac | N/Ac |
RC77T-E | 62 | AA | Epithelial (AR+) | Primary Adenocarcinoma | Poorly differentiated | 7 |
MDA PCa 2b | 63 | AA | Epithelial (AR+) | Adenocarcinoma metastatic bone tumor | N/A | N/A |